SCHEMBL22924101

SCHEMBL22924101

CNc1nn(CC(C)(C)c2c(C)cc(F)c3[nH]nc(N)c23)c2ccc(C)c(C(C)(C)C)c12

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24592387 0.89 — —
SCHEMBL22349086 0.76 KDR (0.37) —
SCHEMBL22924098 0.71 LCK (0.32) —
SCHEMBL25724155 0.71 — —
SCHEMBL20970415 0.70 KDR (0.31) —
SCHEMBL24592467 0.66 — —
SCHEMBL18408663 0.64 MAPT (0.34) —
SCHEMBL22328048 0.63 — —
SCHEMBL22924114 0.63 METAP2 (0.36) —
SCHEMBL24592385 0.63 — —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210024501-A1 COVALENT INHIBITORS OF KRAS ARAXES PHARMA LLC 2021-01-28 — — US disclosed
Send feedback